ESC 365 - Aspirin dosing for secondary prevention - The ADAPTABLE trial.

ESC Premium Access

Aspirin dosing for secondary prevention - The ADAPTABLE trial.

Session: Pragmatic Cardiovascular Trials - A New Approach to Generating Evidence

Topic: Trial Design

Speaker: Professor A. Hernandez (Durham, US)

Event: ESC Congress 2020

Congress Presentation

About the speaker

Professor Adrian Hernandez

Duke Clinical Research Institute, Durham (United States of America)

4 presentations

0 follower

2 more presentations in this session

ABC AF Study: risk score-guided versus standard care in atrial fibrillation.

Speaker: Professor J. Oldgren (Uppsala, SE)

SPIRRIT-HFpEF: spironolactone versus usual care in HFpEF.

Speaker: Professor L. Lund (Stockholm, SE)

Access the full session

Pragmatic Cardiovascular Trials - A New Approach to Generating Evidence

Speakers: Professor A. Hernandez, Professor J. Oldgren, Professor L. Lund

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by